Cyprotex Email Format
Research ServicesEngland, United Kingdom201-500 Employees
Cyprotex is a United Kingdom–based provider of research services focusing on in vitro and in silico ADME-Tox. Founded in 1999, the company operates sites in the UK and USA and has been part of Evotec since a 2016 acquisition. It offers high-throughput ADME screening, customised ADME assays, in silico ADME predictive modeling, and in vitro toxicology. The company is located at Alderley Park, England SK10 4TG, and its workforce is reported to be 201-500 employees. In recent years, Cyprotex closed its Massachusetts offices in July 2023, and its Framingham subsidiary relocated in 2023 to a new facility to support growth of its U.S.-based ADME-Tox services.